Combined Modified RNA Vaccine Candidate (BioNTech)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Combined Modified RNA Vaccine Candidate (BioNTech), covering 2025-12-04 to 2025-12-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. [Phase 3]